Trial intelligence / Profile preview

Vitamin D in Secondary Prevention of Benign Paroxysmal Positional Vertigo

DRKS00011827Phase 3Terminated

Sponsor
German Center for Vertigo and Balance Disorders
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in benign paroxysmal positional vertigo (BPPV) comparing Dekristol with Placebo (2 arms). Started Mar 2017; status: terminated.

02

Drugs

cholecalciferol
03

Conditions

benign paroxysmal positional vertigo (BPPV)

Beyond the preview

Go deeper on DRKS00011827.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00011827.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call